Stable Isotope Reagent Product Detail

Aminomalonamide-13C3

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-103820 Stable Isotope Reagent
Aminomalonamide-13C3
API Family
--
Product Code
CS-T-103820

Aminomalonamide-13C3

Stable Isotope Reagent
Stock Status: : Enquire Live

CAT No.
CS-T-103820
CAS No.
62009-47-6(unlabelled)
Molecular Formula
¹³C₃H₇N₃O₂
Molecular Weight
120.09
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
62009-47-6(unlabelled)
Product Code
CS-T-103820
M.F.
¹³C₃H₇N₃O₂
M.W.
120.09
Smiles
O=[13C](N)[13CH](N)[13C](N)=O
Category
Stable Isotope Reagent
API Family
-
Storage Condition
Refer MSDS for complete information.
IUPAC Name
2-Aminopropanediamide-13C3; 2-Aminomalonamide-13C3
References
Oestereich, L., et al.: Antiviral Res., 105, 17 (2014); Baranovich, T., et al.: J. Virol. 87, 3741 (2013)
Synonyms
2-Aminopropanediamide-13C3; 2-Aminomalonamide-13C3
Application Notes
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.
Hazard Compound
Refer MSDS for complete information.
Overview
Aminomalonamide-13C3 is an intermediate in the synthesis of Favipiravir-13C3 (F103352), which is the isotope labelled analog of Favipiravir. Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever. It is a COVID19-related research product.

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.